Adial Pharmaceuticals Announces Commencement of Landmark ONWARD(TM) Pivotal Phase 3 Trial in Poland Jun 25, 2020
Adial Pharmaceuticals Announces Commencement of the Landmark ONWARD(TM) Pivotal Phase 3 Clinical Trial in Latvia Jun 17, 2020
Adial Pharmaceuticals Closes Previously Announced $5.2 Million Registered Direct Offering Jun 15, 2020
Adial Pharmaceuticals Announces Approval to Commence Landmark ONWARD™ Pivotal Phase 3 Trial in Poland Jun 11, 2020
Adial Pharmaceuticals Announces Pricing of $5.2 Million Registered Direct Offering Priced At-The-Market Jun 9, 2020
Adial Pharmaceuticals and BioLab Sciences Enter into Distribution Agreement for COVID-19 Antibody Tests Jun 8, 2020
Adial Pharmaceuticals Files Post-Effective Amendments to Registration Statements For Outstanding Shares Underlying Existing Warrants and Shelf Registration Statement to Provide Financial Flexibility Apr 23, 2020
